Appendix M: Instruments for Diagnosis <strong>of</strong><strong>Co</strong>-<strong>Occurr<strong>in</strong>g</strong> <strong>Disorders</strong>The <strong>Co</strong>mposite International Diagnostic Interview (CIDI)The CIDI is a structured comprehensive <strong>in</strong>terview developed by <strong>the</strong> World HealthOrganization (WHO) for epidemiological surveys to assess mental disordersaccord<strong>in</strong>g to <strong>the</strong> def<strong>in</strong>itions <strong>and</strong> criteria <strong>of</strong> <strong>the</strong> International Classification <strong>of</strong>Disease (ICD, ICD-10) <strong>and</strong> <strong>the</strong> DSM (DSM-IV). The CIDI is one <strong>of</strong> <strong>the</strong> mostwidely used structured diagnostic <strong>in</strong>terviews <strong>in</strong> <strong>the</strong> world, as it was developedspecifically for use for different cultures <strong>and</strong> sett<strong>in</strong>gs. The <strong>in</strong>strument wasderived from <strong>the</strong> Diagnostic Interview Schedule (DIS; Rob<strong>in</strong>s, Helzer, Croughan,& Ratcliff, 1981) <strong>and</strong> accommodates diagnoses based on <strong>the</strong> def<strong>in</strong>itions <strong>and</strong>criteria <strong>of</strong> <strong>the</strong> ICD <strong>and</strong> DSM. The CIDI was first used <strong>in</strong> 1990, <strong>and</strong> was revised<strong>and</strong> exp<strong>and</strong>ed <strong>in</strong> 1998 by <strong>the</strong> WHO World Mental Health (WMH) <strong>in</strong>itiative toaddress subthreshold impairment, symptom severity <strong>and</strong> persistence, risk factors,<strong>in</strong>ternal <strong>and</strong> external (global) impairment, consequences, patterns <strong>of</strong> treatment,<strong>and</strong> treatment adequacy, <strong>in</strong> addition to diagnosis <strong>of</strong> mental disorders (Kessler &Ustun, 2004). The WMH-CIDI conta<strong>in</strong>s 22 diagnostic sections (<strong>in</strong>clud<strong>in</strong>g anxiety,mood, <strong>and</strong> eat<strong>in</strong>g disorders, tobacco <strong>and</strong> substance use, ADHD, conduct disorder,psychosis, <strong>and</strong> personality disorders), four sections assess<strong>in</strong>g function<strong>in</strong>g <strong>and</strong>physical comorbidity, two sections assess<strong>in</strong>g treatment, seven sections assess<strong>in</strong>gsociodemographics, <strong>and</strong> two sections assess<strong>in</strong>g methodological factors (e.g.,<strong>in</strong>terviewer observations).Positive Features•y The CIDI provides both ICD-10 <strong>and</strong> DSM-IV diagnoses•y A diverse sample was used to develop <strong>the</strong> <strong>in</strong>strument, <strong>in</strong>clud<strong>in</strong>g <strong>in</strong>dividualswith a broad range <strong>of</strong> alcohol <strong>and</strong> drug use severity•y A computerized version <strong>of</strong> <strong>the</strong> CIDI is available, which conta<strong>in</strong>s a scor<strong>in</strong>galgorithm to provide a diagnosis. The computerized version has <strong>the</strong>ability to h<strong>and</strong>le more elaborate “skip” patterns, while cover<strong>in</strong>g <strong>the</strong> same<strong>in</strong>formation as <strong>the</strong> paper <strong>and</strong> pencil version (Andrews & Peters, 2003)•y The WMH-CIDI has been translated <strong>in</strong>to several languages us<strong>in</strong>g <strong>the</strong>st<strong>and</strong>ard WHO translation <strong>and</strong> back-translation protocol•y Adm<strong>in</strong>istration <strong>of</strong> <strong>the</strong> CIDI does not require use <strong>of</strong> mental healthpr<strong>of</strong>essionals or those with significant cl<strong>in</strong>ical tra<strong>in</strong><strong>in</strong>g•y The CIDI diagnoses for alcohol <strong>and</strong> drug dependence have been found tobe reliable, although reliability is generally poor for correspond<strong>in</strong>g harmfuluse <strong>and</strong> abuse diagnoses (Kessler et al., 1998; Ustun et al., 1997)97
<strong>Co</strong>ncerns•y•y•yThe CIDI is quite lengthy <strong>and</strong> requires an average <strong>of</strong> two hours toadm<strong>in</strong>isterUse <strong>of</strong> <strong>the</strong> WMH-CIDI requires completion <strong>of</strong> a tra<strong>in</strong><strong>in</strong>g program thatcovers <strong>in</strong>terview<strong>in</strong>g techniques <strong>and</strong> field quality controlNo data is available regard<strong>in</strong>g <strong>the</strong> <strong>in</strong>strument’s effectiveness <strong>in</strong> crim<strong>in</strong>aljustice sett<strong>in</strong>gsAvailability <strong>and</strong> <strong>Co</strong>stBoth pr<strong>in</strong>table to paper <strong>and</strong> computerized versions <strong>of</strong> <strong>the</strong> CIDI can be obta<strong>in</strong>edfree <strong>of</strong> charge from <strong>the</strong> World Health Organization at http://www3.who.<strong>in</strong>t/cidi/<strong>in</strong>dex.htm.Diagnostic Interview Schedule–Fourth Edition (DIS-IV)The DIS-IV is a fully structured diagnostic <strong>in</strong>terview <strong>in</strong>strument designed forresearch purposes (Blou<strong>in</strong>, Perez, & Blou<strong>in</strong>, 1988; Rob<strong>in</strong>s et al., 1981) <strong>and</strong> hasbeen updated to co<strong>in</strong>cide with revisions to diagnostic categories <strong>in</strong> <strong>the</strong> DSM. Aself-adm<strong>in</strong>istered computerized version <strong>of</strong> <strong>the</strong> DIS is available (C-DIS), althoughstaff must be present to address respondents’ questions. Adm<strong>in</strong>istration <strong>of</strong> <strong>the</strong>DIS does not require cl<strong>in</strong>ical experience. The DIS-IV has 22 modules, which<strong>in</strong>clude demographic <strong>and</strong> risk factors, sequenc<strong>in</strong>g <strong>of</strong> co-morbid disorders,observations <strong>of</strong> psychotic symptoms or o<strong>the</strong>r problems dur<strong>in</strong>g <strong>the</strong> <strong>in</strong>terview,<strong>and</strong> a range <strong>of</strong> <strong>in</strong>dividual modules exam<strong>in</strong><strong>in</strong>g different types <strong>of</strong> disorders relatedto mood, anxiety, eat<strong>in</strong>g, schizophrenia spectrum, somatization, alcohol <strong>and</strong>substance use disorders, antisocial personality disorder, ADHD, dementia, <strong>and</strong>gambl<strong>in</strong>g. The DIS provides <strong>in</strong>formation regard<strong>in</strong>g both current <strong>and</strong> lifetimediagnoses <strong>of</strong> common mental disorders.Positive Features•y The DIS has been used to detect <strong>the</strong> presence <strong>of</strong> psychiatric disorders <strong>in</strong><strong>the</strong> crim<strong>in</strong>al justice system <strong>and</strong> refer deta<strong>in</strong>ees to treatment (Lo, 2004;Tepl<strong>in</strong>, 1990)•y The DIS <strong>in</strong>cludes an Antisocial Personality Disorder module, which iscommonly associated with substance abuse•y The DIS has good agreement with <strong>the</strong> MAST (.79) <strong>in</strong> detect<strong>in</strong>g alcoholismamong <strong>in</strong>dividuals treated for mental disorders (Goe<strong>the</strong> & Fisher, 1995)•y The DIS has good test-retest reliability (95 percent agreement for severedisorders) <strong>in</strong> diagnos<strong>in</strong>g men who are <strong>in</strong>carcerated <strong>in</strong> jail (Abram & Tepl<strong>in</strong>,1991)•y The DIS can be adm<strong>in</strong>istered by non-cl<strong>in</strong>icians, <strong>and</strong> requires m<strong>in</strong>imaltra<strong>in</strong><strong>in</strong>g•y The DIS has been translated <strong>in</strong>to many languages98
- Page 1:
Screening and Assessmentof Co-Occur
- Page 5 and 6:
Screening Instruments for Co-Occurr
- Page 12 and 13:
daunting task, and often requires t
- Page 14 and 15:
Importance of Screening and Assessm
- Page 16 and 17:
•y•y•y•y•y•y•y•y•
- Page 18 and 19:
Developing a Comprehensive Screenin
- Page 20 and 21:
•y•y•y•y•y•y•y•y•
- Page 22 and 23:
These areas of cognitive and behavi
- Page 24 and 25:
•y•y•y•y•y•y•y•yAlc
- Page 26 and 27:
frequency of drug testing may be ta
- Page 28 and 29:
offer expanded tests that also incl
- Page 30 and 31:
self-disclosure of mental health or
- Page 32 and 33:
should be determined by the severit
- Page 34 and 35:
Special Clinical Issues in Screenin
- Page 36:
suicide screening is important for
- Page 39 and 40:
Maintaininga staff ofdiverse ethnic
- Page 41 and 42:
The MHSF-III and the GAIN-SS were f
- Page 43 and 44:
Key Information to Include in Asses
- Page 45 and 46:
•y•y`` Vocational and education
- Page 47 and 48:
approximately two hours. Either the
- Page 49 and 50:
Texas Christian University Drug Scr
- Page 51 and 52:
& Cirimele, 2006). Hair testing can
- Page 53 and 54:
Appendix B: Screening Instruments f
- Page 55 and 56: Suicide Probability Scale (SPS)The
- Page 57 and 58: Positive Features•y•y•yThe TS
- Page 59 and 60: Appendix D: Screening Instruments f
- Page 61 and 62: Positive Features•y•y•y•yTh
- Page 63 and 64: Positive Features•y•y•y•y
- Page 65 and 66: Appendix F: Screening Instruments T
- Page 67 and 68: Availability and CostThe CAMH-CDS i
- Page 69 and 70: and one Axis II disorder (antisocia
- Page 71 and 72: Appendix G: Screening Instruments f
- Page 73 and 74: prior hospitalization for mental he
- Page 75 and 76: •yThe instrument has been used wi
- Page 77 and 78: •yThe instrument has not been use
- Page 79 and 80: Appendix H: Screening Instruments f
- Page 81 and 82: Positive Features•y•y•y•y
- Page 83 and 84: have you felt you ought to Cut down
- Page 85 and 86: Concerns•y•y•yThe DALI was de
- Page 87 and 88: •y•y•y•y•y•y•ywith sc
- Page 89 and 90: Concerns80•y•y•y•y•y•y
- Page 91 and 92: Concerns•y The validity of the SS
- Page 93 and 94: Appendix I: Recommended Instruments
- Page 95 and 96: Concerns•y•y•y•yReliabiliti
- Page 97 and 98: •y•y•y•yScales and profile
- Page 99 and 100: •y•yand non-interpretable resul
- Page 101 and 102: Appendix L: Assessment Instruments
- Page 103 and 104: Philadelphia, PA 19106, (215) 399-0
- Page 105: treatment setting. Treatment progra
- Page 109 and 110: •y•y•yThe PDSQ has been used
- Page 111 and 112: Both a Research Version and a Clini
- Page 113 and 114: 104
- Page 115 and 116: Bastiaens, L., Riccardi, K., & Sakh
- Page 117 and 118: Carey, K. B., Carey, M. P., & Chand
- Page 119 and 120: Demmel, R., Beck, B., Richter, D.,
- Page 121 and 122: Gray, B. T. (2001). A factor analyt
- Page 123 and 124: Kessler, R. C., Wittchen, H. U., Ab
- Page 125 and 126: McLellan, A. T., Cacciola, J. S., &
- Page 127 and 128: Nochajski, T. H., & Stasiewicz, P.
- Page 129 and 130: Rollnick, H., Heather, N., Gold, R.
- Page 131 and 132: Teitelbaum L. M., & Mullen, B. (200
- Page 133: Zimmerman, M., & Sheeran, T. (2003)